735 related articles for article (PubMed ID: 11429421)
1. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
2. ATM mutations in sporadic lymphoid tumours.
Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
[TBL] [Abstract][Full Text] [Related]
3. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.
Vorechovský I; Luo L; Dyer MJ; Catovsky D; Amlot PL; Yaxley JC; Foroni L; Hammarström L; Webster AD; Yuille MA
Nat Genet; 1997 Sep; 17(1):96-9. PubMed ID: 9288106
[TBL] [Abstract][Full Text] [Related]
4. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.
Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I
Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061
[TBL] [Abstract][Full Text] [Related]
5. ATM gene and lymphoid malignancies.
Gumy-Pause F; Wacker P; Sappino AP
Leukemia; 2004 Feb; 18(2):238-42. PubMed ID: 14628072
[TBL] [Abstract][Full Text] [Related]
6. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.
Grønbaek K; Worm J; Ralfkiaer E; Ahrenkiel V; Hokland P; Guldberg P
Blood; 2002 Aug; 100(4):1430-7. PubMed ID: 12149228
[TBL] [Abstract][Full Text] [Related]
7. The ataxia telangiectasia gene in familial and sporadic cancer.
Yuille MA; Coignet LJ
Recent Results Cancer Res; 1998; 154():156-73. PubMed ID: 10026998
[TBL] [Abstract][Full Text] [Related]
8. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances.
Camacho E; Hernández L; Hernández S; Tort F; Bellosillo B; Beà S; Bosch F; Montserrat E; Cardesa A; Fernández PL; Campo E
Blood; 2002 Jan; 99(1):238-44. PubMed ID: 11756177
[TBL] [Abstract][Full Text] [Related]
9. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia.
Schaffner C; Stilgenbauer S; Rappold GA; Döhner H; Lichter P
Blood; 1999 Jul; 94(2):748-53. PubMed ID: 10397742
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the ATM gene in T-cell prolymphocytic leukemias.
Stoppa-Lyonnet D; Soulier J; Laugé A; Dastot H; Garand R; Sigaux F; Stern MH
Blood; 1998 May; 91(10):3920-6. PubMed ID: 9573030
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk and the ATM gene: a continuing debate.
Khanna KK
J Natl Cancer Inst; 2000 May; 92(10):795-802. PubMed ID: 10814674
[TBL] [Abstract][Full Text] [Related]
12. [ATM and Cancer].
Tang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):77-80. PubMed ID: 12513844
[TBL] [Abstract][Full Text] [Related]
13. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.
Stankovic T; Kidd AM; Sutcliffe A; McGuire GM; Robinson P; Weber P; Bedenham T; Bradwell AR; Easton DF; Lennox GG; Haites N; Byrd PJ; Taylor AM
Am J Hum Genet; 1998 Feb; 62(2):334-45. PubMed ID: 9463314
[TBL] [Abstract][Full Text] [Related]
14. Mantle cell lymphoma is characterized by inactivation of the ATM gene.
Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2773-8. PubMed ID: 10706620
[TBL] [Abstract][Full Text] [Related]
15. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage.
Stankovic T; Stewart GS; Fegan C; Biggs P; Last J; Byrd PJ; Keenan RD; Moss PA; Taylor AM
Blood; 2002 Jan; 99(1):300-9. PubMed ID: 11756185
[TBL] [Abstract][Full Text] [Related]
16. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia.
Stilgenbauer S; Schaffner C; Litterst A; Liebisch P; Gilad S; Bar-Shira A; James MR; Lichter P; Döhner H
Nat Med; 1997 Oct; 3(10):1155-9. PubMed ID: 9334731
[TBL] [Abstract][Full Text] [Related]
17. ATM mutations in B-cell chronic lymphocytic leukemia.
Bullrich F; Rasio D; Kitada S; Starostik P; Kipps T; Keating M; Albitar M; Reed JC; Croce CM
Cancer Res; 1999 Jan; 59(1):24-7. PubMed ID: 9892178
[TBL] [Abstract][Full Text] [Related]
18. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
[TBL] [Abstract][Full Text] [Related]
19. The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo.
Weston VJ; Oldreive CE; Skowronska A; Oscier DG; Pratt G; Dyer MJ; Smith G; Powell JE; Rudzki Z; Kearns P; Moss PA; Taylor AM; Stankovic T
Blood; 2010 Nov; 116(22):4578-87. PubMed ID: 20739657
[TBL] [Abstract][Full Text] [Related]
20. Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene.
Meyn MS
Clin Genet; 1999 May; 55(5):289-304. PubMed ID: 10422797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
